Financials data is unavailable for this security.
View more
Year on year Laboratory Corporation of America Holdings 's net income fell -67.32% from 1.28bn to 418.00m despite relatively flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 68.74% to 72.33%.
| Gross margin | 28.00% |
|---|---|
| Net profit margin | 3.61% |
| Operating margin | 5.97% |
| Return on assets | 2.62% |
|---|---|
| Return on equity | 5.35% |
| Return on investment | 3.20% |
More ▼
Cash flow in USDView more
In 2023, Laboratory Corporation of America Holdings increased its cash reserves by 24.84%, or 106.80m. The company earned 1.33bn from its operations for a Cash Flow Margin of 10.92%. In addition the company used 1.17bn on investing activities and also paid 59.30m in financing cash flows.
| Cash flow per share | 12.38 |
|---|---|
| Price/Cash flow per share | 17.88 |
| Book value per share | 95.53 |
|---|---|
| Tangible book value per share | -18.45 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.8786 |
|---|---|
| Quick ratio | 0.7699 |
| Total debt/total equity | 0.6433 |
|---|---|
| Total debt/total capital | 0.391 |
More ▼
Growth rates in USD
SmartText is unavailable
| Div yield(5 year avg) | 0.44% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 55.17% |
| EPS growth(5 years) | -13.71 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -30.26 |
More ▼
